Short Summary
Micron Technology, Inc. successfully convinced the PTAB that Yangtze Memory Technologies Company, Ltd.'s semiconductor patent was obvious over prior art reference Toyama et al., leading to institution of the IPR. The Board found Petitioner demonstrated a reasonable likelihood of prevailing on all 8 claims at issue based on structural limitations taught by the prior art.
Detailed Summary
Micron Technology, Inc. petitioned for institution of an Inter Partes Review (IPR) against Yangtze Memory Technologies Company, Ltd.'s patent (10658378), alleging obviousness over Toyama et al. US 2017/0179026 A1. The PTAB ultimately granted institution, finding that Micron demonstrated a reasonable likelihood of prevailing on all eight claims at issue (1, 2, 3, 4, 5, 6, 7, and 18). This decision hinged on the Board's acceptance that key structural limitations, such as 'substrate with an isolation region' and 'a dielectric structure,' were adequately taught by various embodiments within the Toyama prior art. Although the Patent Owner raised a § 325(d) argument regarding prior consideration, the Board determined this was overcome because Petitioner sufficiently showed the Office erred in its evaluation of the reference.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Micron Technology, Inc. et al. vs Yangtze Memory Technologies Company, Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Perfect CorporationvsZugara, Inc.
Perfect Corp. and Zugara, Inc. settled their IPR dispute over patent 10,482,517. The Board granted a joint motion to terminate the proceeding and kept the settlement agreement confidential.
Abbott Laboratories et al.vsMIRACOR MEDICAL SA
The PTAB denied Director Review requests for three IPR institution decisions, including IPR2025-00115 concerning patent 11,674,517 owned by Miracor Medical and challenged by Abbott Laboratories. The institution decisions therefore remain in effect.
Avation Medical, Inc.vsEMKinetics, Inc.
Avation Medical has filed an IPR petition challenging EMKinetics' U.S. Patent 11,224,742 covering non‑invasive posterior tibial nerve stimulation for overactive bladder. The petition argues the claims are obvious over prior‑art references such as Svihra, Amarenco, Mann and Ponsford and seeks institution of the trial.
Intel Corporation et al.vsTelefonaktiebolaget LM Ericsson
Intel has filed a petition for Director Review challenging the PTAB's denial to institute an IPR against Ericsson's 10,142,659 patent covering a deblocking filter in video codecs. Intel argues the Board misapplied obviousness standards regarding result‑effective variables. The petition seeks reversal of the denial and institution of the trial.
Bizlink Technology, Inc., et al.vsAnder Power Products, Inc.
The PTAB denied Bizlink Technology's request for Director Review of the Final Written Decision in IPR2024-00687 concerning patent 8,808,017. The prior decision remains in effect.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.